Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Comparison of ECG Changes with Propofol vs Sevoflurane in Cochlear Implantation
IRCT2017082131487N2Phase 3Completed
- Sponsor
- Iran University of Medical Sciences
- Start
- Sep 2017
- Modality
- Small Molecules
- Countries
- 1
01
Overview
Phase 3 trial of propofol and sevoflurane in sensorineural hearing loss (SNHL) (2 arms), sponsored by Iran University of Medical Sciences. Primary endpoint: Change in ECG parameters during cochlear implantation. Started Sep 2017; status: completed.
02
Drugs
propofolsevoflurane
03
Conditions
sensorineural hearing loss (SNHL)
Beyond the preview
Go deeper on IRCT2017082131487N2.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on IRCT2017082131487N2.